Treatment of different prion strains with PPI in vitro. (A) Samples containing 1% (wt/vol) brain homogenates were incubated for 2 h at 37°C with 60 μg of PPI generation 4.0/ml. Paired lanes are designated as follows: 1, SHa(Sc237); 2, SHa(139H); 3, SHa(DY); 4, SHa(RML); 5, Tg(MH2M)Prnp0/0(RML); 6, Tg(PrP106)Prnp0/0(RML); 7, Mo(RML); 8, Mo(Me7); 9, Mo(22a); 10, Mo(87V); 11, Mo(139A); 12, Mo(C506). Minus symbols denote untreated, control samples and plus symbols designate samples exposed to 60 μg of PPI generation 4.0/ml for 2 h at 37°C. (B) Samples containing 1% (wt/vol) Mo(RML) or SHa(Sc237) were incubated at 37°C with 60 μg of PPI generation 4.0/ml or control buffer for the time periods indicated. For panels A and B, all samples possessed equivalent protein concentrations and were subjected to limited proteolysis. Apparent molecular masses based on migration of protein standards are 30 and 27 kDa. (C) Brain homogenates from Tg(BoPrP)Prnp0/0 mice were incubated with 60 μg of PPI generation 4.0/ml or control buffer. Lanes: 1, Tg(BoPrP)Prnp0/0 (sheep scrapie); 2, Tg(BoPrP)Prnp0/0 (sheep scrapie) plus PPI; 3, Tg(BoPrP)Prnp0/0 (BSE); 4, Tg(BoPrP)Prnp0/0 (BSE) plus PPI. Minus symbols denote undigested, control samples and plus symbols designate samples subjected to limited proteolysis. All samples possessed equivalent protein concentrations prior to proteolysis. Apparent molecular masses based on migration of protein standards are 30 and 27 kDa.